Ftse Mib
32.929,39
0,81%
DAX
18.068,21
0,26%
S&P 500
5.486,79
1,02%
NASDAQ
17.912,46
1,26%
Bitcoin
66.789,77
0,23%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ New River Pharmaceuticals (MM) (NRPH) New River Pharmaceuticals (MM) (NRPH) Notizie

NRPH

New River (NRPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NRPH
DataOraFonteTitoloSimboloCompagnia
18/04/200722:41PR Newswire (US)HealthShares(TM) Announces Changes to the HealthShares(TM) Neuroscience and Composite IndicesNASDAQ:NRPHNew River Pharmaceuticals (MM)
03/04/200715:00PR Newswire (US)New River Pharmaceuticals Inc. Announces Convertibility of 3.50% Convertible Subordinated Notes Due 2013NASDAQ:NRPHNew River Pharmaceuticals (MM)
19/03/200715:00PR Newswire (US)New River Announces Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:NRPHNew River Pharmaceuticals (MM)
14/03/200700:30PR Newswire (US)New River Pharmaceuticals Announces Year-End ResultsNASDAQ:NRPHNew River Pharmaceuticals (MM)
23/02/200723:07PR Newswire (US)Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug VYVANSE(TM) (lisdexamfetamineNASDAQ:NRPHNew River Pharmaceuticals (MM)
20/02/200712:00PR Newswire (US)New River Pharmaceuticals to be Acquired by Shire plc for $64 per ShareNASDAQ:NRPHNew River Pharmaceuticals (MM)
05/02/200716:18PR Newswire (US)New River Pharmaceuticals to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical ConferenceNASDAQ:NRPHNew River Pharmaceuticals (MM)
25/01/200721:01PR Newswire (US)James Shaffer Joins New River Pharmaceuticals as Vice President, Sales and MarketingNASDAQ:NRPHNew River Pharmaceuticals (MM)
22/12/200605:34PR Newswire (US)New River Pharmaceuticals and Shire Receive Approvable Letter for VYVANSE(TM) (lisdexamfetamine dimesylate) for the Treatment ofNASDAQ:NRPHNew River Pharmaceuticals (MM)
07/11/200623:22PR Newswire (US)New River Pharmaceuticals Announces Third Quarter 2006 ResultsNASDAQ:NRPHNew River Pharmaceuticals (MM)
30/10/200615:00PR Newswire (US)Interim Results of a Phase III Trial of Lisdexamfetamine Dimesylate (NRP104/LDX) in ADHD Presented at Major Scientific MeetingNASDAQ:NRPHNew River Pharmaceuticals (MM)
13/10/200615:45PR Newswire (US)New River Pharmaceuticals Conducts End-of-Phase II Meeting with FDA for NRP290NASDAQ:NRPHNew River Pharmaceuticals (MM)
07/10/200603:25PR Newswire (US)FDA Issues Approvable Letter for NRP104 (lisdexamfetamine dimesylate) for the Treatment of ADHDNASDAQ:NRPHNew River Pharmaceuticals (MM)
07/10/200603:23PR Newswire (US)New River Pharmaceuticals Inc. Receives Approvable Letter for NRP104NASDAQ:NRPHNew River Pharmaceuticals (MM)
03/10/200623:20PR Newswire (US)Dr. Garen Manvelian Joins New River Pharmaceuticals as Chief Medical OfficerNASDAQ:NRPHNew River Pharmaceuticals (MM)
12/09/200621:00PR Newswire (US)New River Pharmaceuticals Inc. Meets Enrollment in NRP104 Adult Phase III StudyNASDAQ:NRPHNew River Pharmaceuticals (MM)
08/09/200623:38PR Newswire (US)New River Pharmaceuticals to Present at the Bear Stearns 19th Annual Healthcare ConferenceNASDAQ:NRPHNew River Pharmaceuticals (MM)
18/08/200600:03PR Newswire (US)New River Pharmaceuticals Names Dr. Samir Roy Vice President, Formulation and ManufacturingNASDAQ:NRPHNew River Pharmaceuticals (MM)
08/08/200623:46PR Newswire (US)New River Pharmaceuticals Announces Second Quarter 2006 ResultsNASDAQ:NRPHNew River Pharmaceuticals (MM)
25/07/200622:58PR Newswire (US)New River Pharmaceuticals Announces Exercise of Co-Promotion Option in the U.S. for NRP104NASDAQ:NRPHNew River Pharmaceuticals (MM)
25/07/200618:57PR Newswire (US)New River Pharmaceuticals Closes Sale of $135,000,000 Convertible Subordinated NotesNASDAQ:NRPHNew River Pharmaceuticals (MM)
24/07/200615:41Business WireAMRI Announces Long-Term Manufacturing Agreement with New River PharmaceuticalsNASDAQ:NRPHNew River Pharmaceuticals (MM)
20/07/200603:06PR Newswire (US)New River Pharmaceuticals Prices $125 Million Convertible Subordinated Notes; Company to Repurchase Up to $51 million in CommonNASDAQ:NRPHNew River Pharmaceuticals (MM)
18/07/200623:26PR Newswire (US)New River Pharmaceuticals Announces Proposal to Offer $125 Million Convertible Subordinated Notes; Company to Repurchase up toNASDAQ:NRPHNew River Pharmaceuticals (MM)
30/06/200616:31PR Newswire (US)New River Pharmaceuticals Announces Filing of Investigational New Drug Application for NRP409NASDAQ:NRPHNew River Pharmaceuticals (MM)
23/06/200618:52PR Newswire (US)New River Pharmaceuticals to Host Conference Call on A01, A02 and A03 Clinical Abuse Liability Studies of NRP104NASDAQ:NRPHNew River Pharmaceuticals (MM)
20/06/200623:30PR Newswire (US)New River Pharmaceuticals Provides Detail on A02 Clinical Abuse Liability Study of NRP104NASDAQ:NRPHNew River Pharmaceuticals (MM)
18/06/200623:45PR Newswire (US)New River Pharmaceuticals Provides Detail on A01 Clinical Abuse Liability Study and Announces Results from A03 StudyNASDAQ:NRPHNew River Pharmaceuticals (MM)
14/06/200615:01PR Newswire (US)New River Pharmaceuticals to Present Results from NRP104 Abuse Liability StudiesNASDAQ:NRPHNew River Pharmaceuticals (MM)
31/05/200600:33PR Newswire (US)New River Pharmaceuticals to Present at the Friedman Billings Ramsey 2006 Growth Investor ConferenceNASDAQ:NRPHNew River Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NRPH

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network